国产精品天干天干,亚洲毛片在线,日韩gay小鲜肉啪啪18禁,女同Gay自慰喷水

歡迎光臨散文網(wǎng) 會員登陸 & 注冊

BXC-SIM0010體內(nèi)SIM人類PD-1抗體(帕博利珠單抗生物類似藥)

2023-03-17 14:42 作者:艾美捷  | 我要投稿

Product Details

This non-therapeutic biosimilar antibody uses the same variable regions from the therapeutic antibody Pembrolizumab making it ideal for research use. This Pembrolizumab biosimilar reacts with human PD-1 (programmed death-1) also known as CD279. PD-1 is a 50-55 kDa cell surface receptor encoded by the Pdcd1 gene that belongs to the CD28 family of the Ig superfamily. PD-1 is transiently expressed on CD4 and CD8 thymocytes as well as activated T and B lymphocytes and myeloid cells. PD-1 expression declines after successful elimination of antigen. Additionally, Pdcd1 mRNA is expressed in developing B lymphocytes during the pro-B-cell stage. PD-1’s structure includes a ITIM (immunoreceptor tyrosine-based inhibitory motif) suggesting that PD-1 negatively regulates TCR signals. PD-1 signals via binding its two ligands, PD-L1 and PD-L2 both members of the B7 family. Upon ligand binding, PD-1 signaling inhibits T-cell activation, leading to reduced proliferation, cytokine production, and T-cell death. Additionally, PD-1 is known to play key roles in peripheral tolerance and prevention of autoimmune disease. Induced PD-L1 expression is common in many tumors including squamous cell carcinoma, colon adenocarcinoma, and breast adenocarcinoma. PD-L1 overexpression results in increased resistance of tumor cells to CD8 T cell mediated lysis. PD-L1 overexpression results in increased resistance of tumor cells to CD8 T cell mediated lysis. In experimental models of melanoma, tumor growth can be transiently arrested via treatment with antibodies which block the interaction between PD-L1 and its receptor PD-1. For these reasons anti-PD-1 mediated immunotherapies are currently being used as cancer treatments. Pembrolizumab binds to PD-1 on activated immune cells to selectively block the interaction of PD-1 with its ligands.

?

BXC-SIM0010體內(nèi)SIM人類PD-1抗體(帕博利珠單抗生物類似藥):

這種非治療性生物仿制藥抗體使用與治療性抗體Pembrolizumab相同的可變區(qū)域,使其成為研究用途的理想選擇。這種Pembrolizumab生物仿制藥與人PD-1(程序性死亡-1)反應(yīng),也稱為CD279。PD-1是由Pdcd50基因編碼的55-1 kDa細(xì)胞表面受體,屬于Ig超家族的CD28家族。PD-1在CD4和CD8胸腺細(xì)胞以及活化的T和B淋巴細(xì)胞和骨髓細(xì)胞上短暫表達(dá)。PD-1在成功消除抗原后表達(dá)下降。

?

?

BioXCell艾美捷體內(nèi)SIM人類PD-1抗體(帕博利珠單抗生物類似藥)規(guī)格:

# ?BXC-SIM0010

Isotype?Human IgG4

Recommended Isotype Control(s)?RecombiMAb human IgG4 (S228P) isotype control, anti-hen egg lysozyme

Recommended Dilution Buffer?InVivoPure pH 7.0 Dilution Buffer

Immunogen?Human PD-1

Reported Applications?Blocking of PD-1/PD-L signaling

Functional assays

Formulation?PBS, pH 7.0

Contains no stabilizers or preservatives

Endotoxin?<1EU/mg (<0.001EU/μg)

Determined by LAL gel clotting assay

Aggregation?<5%

Determined by DLS

Purity?>95%

Determined by SDS-PAGE

Sterility?0.2 μM filtered

Production?Purified from cell culture supernatant

Purification?Protein A

RRID?AB_2894731

Molecular Weight?150 kDa

Murine Pathogen Tests?Ectromelia/Mousepox Virus: Negative

Hantavirus: Negative

K Virus: Negative

Lactate Dehydrogenase-Elevating Virus: Negative

Lymphocytic Choriomeningitis virus: Negative

Mouse Adenovirus: Negative

Mouse Cytomegalovirus: Negative

Mouse Hepatitis Virus: Negative

Mouse Minute Virus: Negative

Mouse Norovirus: Negative

Mouse Parvovirus: Negative

Mouse Rotavirus: Negative

Mycoplasma Pulmonis: Negative

Pneumonia Virus of Mice: Negative

Polyoma Virus: Negative

Reovirus Screen: Negative

Sendai Virus: Negative

Theiler’s Murine Encephalomyelitis: Negative

Storage?The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.

同種型?人免疫球蛋白G4

推薦的同種型對照?RecombiMAb人IgG4(S228P)同種型對照,抗母蛋溶菌酶

推薦的稀釋緩沖液?體內(nèi)純?pH 7.0 稀釋緩沖液

免疫原?人類PD-1

報告的應(yīng)用程序?阻斷PD-1/PD-L信號傳導(dǎo)

功能檢測

配方?PBS,pH 7.0

不含穩(wěn)定劑或防腐劑

內(nèi)毒素?<1EU/mg (<0.001EU/μg)

通過LAL凝膠凝血測定法測定

集合體?<5%

由?DLS 確定

純度?>95%

由?SDS-PAGE 決定

無?菌?0.2 μM 過濾

生產(chǎn)?從細(xì)胞培養(yǎng)上清液中純化

純化?蛋白A

里德?AB_2894731

分子量?150 千達(dá)

鼠病原體檢測?外切粒菌/鼠痘病毒: 陰性 漢坦病毒: 陰性 K 病毒: 陰性乳酸脫氫酶升高病毒: 陰性 淋巴細(xì)胞性脈絡(luò)叢腦膜炎病毒: 陰性小鼠腺病毒: 陰性小鼠巨細(xì)胞病毒: 陰性小鼠肝炎病毒: 陰性小鼠分鐘病毒: 陰性小鼠諾如病毒: 陰性小鼠細(xì)小病毒: 陰性

小鼠輪狀病毒:肺支原體陰性:陰性?小鼠肺炎病毒:陰性?多瘤病毒:陰性呼腸孤病毒篩查:陰性?仙臺病毒:陰性?泰勒鼠腦脊髓炎:陰性

存儲?抗體溶液應(yīng)以4°C的儲備濃度儲存。 不要凍結(jié)。


BXC-SIM0010體內(nèi)SIM人類PD-1抗體(帕博利珠單抗生物類似藥)的評論 (共 條)

分享到微博請遵守國家法律
夹江县| 枝江市| 会东县| 玉山县| 射洪县| 墨脱县| 平顺县| 黔南| 郯城县| 隆回县| 九寨沟县| 皋兰县| 昂仁县| 南江县| 黄梅县| 株洲市| 登封市| 岱山县| 宣化县| 普兰县| 吉林省| 司法| 金川县| 新泰市| 集贤县| 陇西县| 什邡市| 微山县| 新兴县| 建湖县| 景泰县| 确山县| 岐山县| 浦江县| 金昌市| 客服| 陵川县| 泰州市| 资中县| 宝兴县| 乐亭县|